Clinical Trials Directory

Trials / Conditions / Hypopharynx Squamous Cell Carcinoma

Hypopharynx Squamous Cell Carcinoma

7 registered clinical trials studyying Hypopharynx Squamous Cell Carcinoma — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Canc
NCT07063212
Memorial Sloan Kettering Cancer CenterPhase 2
WithdrawnA Study of Concurrent Chemoradiation in Combination With or Without PD1 Inhibitor AB122 Adenosine 2a Receptor
NCT04892875
Jennifer ChoePhase 1
RecruitingPersonalized Elective Neck Irradiation Guided by Sentinel Lymph Node Biopsy in Larynx and Pharynx Cancer. The
NCT05333523
Radboud University Medical CenterPhase 3
RecruitingFirst Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
NCT04858269
Wake Forest University Health SciencesPhase 2
TerminatedActivity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Ne
NCT04445064
Cliniques universitaires Saint-Luc- Université Catholique de LouvainPhase 2
CompletedIRX-2 Regimen and Durvalumab, for Incurable H&N Squamous Cell Carcinoma
NCT03381183
H. Lee Moffitt Cancer Center and Research InstitutePhase 1
CompletedWEE1 Inhibitor with Cisplatin and Radiotherapy: a Trial in Head and Neck Cancer
NCT03028766
University of BirminghamPhase 1